Acquisition des résistances au cours du temps
4
……….. (2005) S. aureus and Enterococci Daptomicine
….(1999) S. aureus and Enterococcus Linezolid
(1986) PseudomonasImipenem
(1981) CefotaximeEnterobactérie
GentamicinS. aureus (1969)Nalidíxic acid E. coli (1996)
Vancomycine VRE, VRSA 1988 / 2004
MethicilineMRSA (1961)
ErythromycinS. aureus (1956)
Tetracycline Shigella dysenterie(1952)
Streptomycine Myco tb (1947)
Pencillin G PRSA (1940)
.......
1920 1930 1940 1950 1960 1970 1980 1990 2000
Matthew Dryden - Clinical Director of Microbiology and Communicable Disease
Royal Hampshire Hospital, Winchester, UK